Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Orforglipron for Sale > Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - large image1
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - image1
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - image2
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - image3
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - image4
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - image5
Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3 buy - image6

Hot Sale, Factory Direct, High Purity Orforglipron, CAS 2212020-52-3

ISO COA 29 Inquiries

Unit Price:

$0.98-1.12/KG FOB

Get Latest Price
CAS No.:

2212020-52-3

Grade:

Pharmaceutical Grade

Content:

98%

Port:

QD

Packaging:

BAG

Sample Available:

Yes

Price valid (until):

2026-11-15

Company Type:
Trader
Location:
Hongkong, China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Orforglipron is reported in literature as a newly synthesized oral non-peptide compound. Relevant studies indicate it can enhance glucose-dependent insulin secretion and modulate energy balance in research models.

    Storage Condition: Store at -20°C Solubility: DMSO: 125 mg/mL (141.57 mM) Form: Solid pKa: 7.33 ± 0.20 (Predicted) Color: Off-white to pale yellow solid



    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 1
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 2
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 3
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 4
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 5
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 6
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 7
    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 8


    Company  


    1. Any problems, compensation or reissue
    2. Dedication to quality, & service.
    3. Professional sales provide professional services and suggestions.
    4. Reasonable & competitive price, lead time is 1 day.
    5. Sample is available for your evaluation & formulation development.
    6. Strict and sound quality management system-Put all the production in the quality management system and service in all respects for the customers.
    7. Experienced production group-Delicacy management system-Put all the production in the quality management system.

    Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 9 Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 10



    Our factory



    Since the establishment of our company's foreign trade export business, through the unremitting efforts of the company team, our export business has achieved very good results. Our products are exported to USA, Japan, Korea, Singapore, India, UK, Russia, France, Algeria and other countries and has got a good customer feedback and trust. Shop High Quality High Purity Orforglipron CAS 2212020-52-3 Factory Direct Supply-Detailed Image 11

    ECHEMI Editorial Reference
    Orforglipron (LY3502970) (GLP-1 receptor agonist 1) is  GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67.
    Orforglipron is an oral, non-peptide, small-molecule glucagon-like peptide-1 receptor agonist developed by Eli Lilly and Company as a weight-loss drug. Currently, the drug is still in Phase III clinical trials and has not yet received approval from the U.S. Food and Drug Administration (FDA). Eli Lilly's CEO expects the FDA to approve its investigational oral weight-loss drug, orforglipron, by March 2026, and to submit an application for the treatment of type 2 diabetes by the end of 2026.

    Certificates

    Basic Info
    Product Name:

    Orforglipron

    Other Name:

    1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron(LY3502970);LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833

    CAS No.:

    2212020-52-3

    Molecular Formula:

    C48H48F2N10O5

    InChIKeys:

    USUWIEBBBWHKNI-BBGRWQLENA-N

    Molecular Weight:

    882.97

    EC Number:

    278-636-5

    Color/Form:

    Off-white to light yellow

    Categories:

    Other Chemical Drugs

    Characteristics
    Density:

    1.50±0.1 g/cm3(Predicted)

    PKA:

    7.33±0.20(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    Bulgaria

    orforglipron

    1 KG Aug 27, 2025
    United Kingdom

    Orforglipron

    1000 MT Oct 17, 2026
    Austria

    Orforglipron

    1000 MT Jun 12, 2026
    Switzerland

    Orforglipron

    10 MG Apr 25, 2026
    United States

    Orforglipron

    20 G Apr 3, 2026
    United States

    Orforglipron

    10 G Mar 29, 2026
    United States

    oforglipron

    3 KG Jul 4, 2025
    Switzerland

    Orforglipron

    100 G Sep 25, 2026
    India

    orforglipron

    1.00 G Jul 16, 2026
    United States

    orforglipron

    10 G Apr 20, 2026
    United States

    Orforglipron

    10 G Apr 6, 2026
    United States

    orforglipron

    1 G Mar 24, 2026
    Germany

    Orforglipron

    2 G Mar 23, 2026
    Bangladesh

    Orforglipron

    500.00 KG Mar 9, 2026
    United States

    Orforglipron

    10 G Feb 28, 2026
    United Kingdom

    Orforglpron

    50 G Feb 12, 2026
    United States

    orforglipron

    1 KG Feb 6, 2026
    Lithuania

    Orforglipron

    6 G Jan 23, 2026
    China

    Orforglipron

    50 KG Nov 10, 2025
    United Kingdom

    Orforglipron

    1 G Jul 9, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.